UK 3D printing medical devices market size was valued at $77 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 14.3% from 2022 to 2030 and will reach $ 225 Mn in 2030. The market is segmented by component, application, technology, and end user. This market will grow as the development of new 3D printing materials and techniques has led to the production of more complex and customizable medical devices. The key market players are Renishaw plc, Sutrue, Axial3D, Adapttech, FDM Digital Solutions, 3D LifePrints, Opro Mouthguards, Toffeln, PrintLab, Added Scientific, and others.
The UK 3D Printing Medical Devices Market size is at around $77 Mn in 2022 and is projected to reach $225 Mn in 2030, exhibiting a CAGR of 14.30% during the forecast period. Around 45% of all UK government spending on products and services in 2022 went toward healthcare. About 4.5% of the average citizen's income, or about 18% of income tax, is allocated to healthcare. In total, the UK's gross domestic product is spent on healthcare at an average rate of 8.4 percent.
A three-dimensional object is produced using the 3D printing method by adding successive layers of raw materials. Layers are added one on top of the other until the thing is finished. A digital 3D file, such as a Computer-Aided Design (CAD) sketch or a magnetic resonance image, is used to create an object. Designing and testing to produce useful objects is now the main goal of 3D printing. Due to the fact that 3D printing doesn't require tooling, unlike conventional production methods, it can help businesses get past challenges like prohibitively expensive tooling. Low-volume manufacturing is more expensive than conventional manufacturing despite having reduced unit costs because of high initial tooling costs. The quantity of waste produced during the manufacturing process is decreased by 3D printing by layering components. The ability to mass customizes products, particularly for small production runs, is another area where 3D printing excels over conventional manufacturing.
3D printing applications are increasing rapidly in the medical industry and are expected to revolutionize health care. The medical industry employs 3D printing in several general categories, including tissue and organ fabrication, customized prosthetics, implants, anatomical models, and pharmaceutical studies related to drug dosage forms, delivery, and discovery. It offers several advantages, such as customization and personalization of medical products, drugs, and equipment, cost-effectiveness, and efficient productivity.
Market Growth Drivers
The demand for 3D Printing Medical devices has increased as chronic illnesses like diabetes, cancer, and cardiovascular disease are becoming more common in the UK. With the aid of 3D printing technology, medical devices can be produced more precisely, dependably, and effectively, which can enhance patient outcomes and lower healthcare expenses. The creation of innovative medical devices can be completed much faster with the aid of 3D printing technology. Because of this, manufacturers may be able to introduce new products to the market more rapidly, giving them a competitive advantage. The demand for specialized medical devices in the UK that can be tailored to specific patient requirements has increased due to the increasing trend toward personalized medicine. The ability to produce highly customized medical devices credit to 3D printing technology makes it a desirable choice for manufacturers.
Market Restraints
3D printing in the UK offers a broad range of customization and design options, but the selection of materials is still quite small. This may restrict the use of medical devices made using 3D printing and make it challenging for manufacturers to create some products in the UK. 3D printing in the UK, medical devices are subject to stringent safety and efficacy regulations. As a result, new manufacturers may find it difficult to enter the market because they must navigate complicated regulatory frameworks and acquire the required certifications.
Key Players
October 2022: A medical 3D printing business with headquarters in the UK, 3D LifePrints, declared in October 2022 that it had received $1.45 Mn in financing from NPIF-Mercia Equity Finance, which it intended to use to grow its business and create new devices.
The Medicines and Healthcare Products Regulatory Agency (MHRA), which is in charge of making sure that medical devices adhere to strict performance and safety requirements, regulates the 3D printing medical device industry in the UK. Manufacturers must abide by the Medical Devices Regulation 2017/745 (MDR) and the In Vitro Diagnostic Medical Devices Regulation 2017/746 (IVDR) in order to market 3D-printed medical devices in the UK. These laws specify the specifications for medical devices, such as the requirement for suitable clinical evidence, risk evaluations, and labeling. The MHRA also issued recommendations on 3D-printed medical devices, outlining the legal requirements and factors that manufacturers should consider. This advice addresses issues like post-market monitoring, material safety, and software validation.
1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country
2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)
3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints
4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)
4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)
5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment
6. Methodology and Scope
By Component
The UK market is divided into three categories based on the component: equipment, materials, and software & services. End customers frequently employ software and services for designing and process control of 3D printed medical devices, particularly for bespoke items. The cost-effectiveness, utility, uniformity, and precision given by services for medical device 3D printing, together with a rise in demand for personalised 3D printed medical equipment among hospitals and surgical centres, are driving the market demand for software & surgical guides.
By Application
The UK market is divided into surgical guides, surgical tools, tissue-engineered goods, hearing aids, wearable medical devices/implantable medical devices, standard prostheses and implants, custom prosthetics and implants, and other medical devices based on the application. Due to the widespread adoption of 3D printing technology in the production of prosthetics and implants, the increased availability of high-quality biomaterials and ceramics for 3D printing, and ongoing industry investment in the development of novel 3D printers, the custom prosthetics and implants segment is expected to hold a larger share of the market in 2022.
By Technology
According to technology, the global market has been divided into three categories: three-dimensional printing (3DP) or adhesion bonding; electron beam melting (EBM); laser beam melting (LBM); photopolymerization; droplet deposition or extrusion-based technologies; and other technologies. The laser beam melting (LBM) segment is anticipated to hold the greatest market share in 2022, in large part due to the growing use of this technology in the dental sector and for the production of implants for minimally invasive surgery.
By End User
The UK market has been divided into hospitals and surgical facilities, dental and orthopaedic clinics, academic institutions and research labs, pharma-biotech and medical device firms, and clinical research organisations based on end users. In 2022, hospitals and surgical centres are anticipated to hold the greatest market share. The high proportion of this market may be due to the ongoing expansion of internal 3D printing capabilities, the expansion of existing 3D printing laboratories, the rising affordability of 3D printing services, and the quick uptake of cutting-edge technology by hospitals in developed markets.
Methodology for Database Creation
Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.
Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.
How Do We Get It?
Our database is created and maintained through a combination of secondary and primary research methodologies.
1. Secondary Research
With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:
With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:
2. Primary Research
To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:
Combining Secondary and Primary Research
By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:
Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.